secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2026-04-03T23:59:59+00:00
Accession:  0001193125-26-141187
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics schedules 2025/2026 Annual Meeting for May 8, 2026
----------------------------------------------------------------------

- Stockholder proposal/nomination deadline set for April 13, 2026.
- Meeting date is more than 60 days after 2024 Annual Meeting; new deadlines apply.
- Universal proxy rule (Rule 14a-19) notice also due by April 13, 2026.
- Proposals for inclusion in proxy materials must be received by April 13, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526141187/0001193125-26-141187-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526141187/d117348d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-141187

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer